These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28987613)
1. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review. Bakthavatchalam M; Lai FHP; Rong SS; Ng DS; Brelen ME Surv Ophthalmol; 2018; 63(3):329-339. PubMed ID: 28987613 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Grover S; Fishman GA; Fiscella RG; Adelman AE Retina; 1997; 17(3):222-31. PubMed ID: 9196934 [TBL] [Abstract][Full Text] [Related]
3. DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study. Colombo L; Montesano G; Di Domenico A; Colizzi B; Rissotto R; Maltese P; Bertelli M; Autelitano A; Rossetti L Retina; 2024 May; 44(5):852-860. PubMed ID: 38166238 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa. Veritti D; Sarao V; De Nadai K; Chizzolini M; Parmeggiani F; Perissin L; Lanzetta P J Ocul Pharmacol Ther; 2020 Apr; 36(3):190-197. PubMed ID: 31886707 [No Abstract] [Full Text] [Related]
5. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Liew G; Moore AT; Webster AR; Michaelides M Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491 [TBL] [Abstract][Full Text] [Related]
6. Protocol for the treatment of cystoid macular edema secondary to retinitis pigmentosa and other inherited retinal dystrophies. Català-Mora J; Santamaría Álvarez JF; Kyriakou D; Alforja S; Barraso Rodrigo M; Blasco Palacio PB; Casaroli-Marano R; Cobos Martín E; Coco Martín RM; Esmerado C; García Tirado A; García P; Gómez-Benlloch A; Rodríguez Fernández CA; Vilaplana Mira F Arch Soc Esp Oftalmol (Engl Ed); 2024 Feb; 99(2):67-81. PubMed ID: 37940089 [TBL] [Abstract][Full Text] [Related]
7. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Karasu B Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389 [TBL] [Abstract][Full Text] [Related]
9. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. Strong S; Liew G; Michaelides M Br J Ophthalmol; 2017 Jan; 101(1):31-37. PubMed ID: 27913439 [TBL] [Abstract][Full Text] [Related]
10. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Apushkin MA; Fishman GA; Grover S; Janowicz MJ Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255 [TBL] [Abstract][Full Text] [Related]
11. Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide. Schaal Y; Hondur AM; Tezel TH Can J Ophthalmol; 2016 Aug; 51(4):e113-e115. PubMed ID: 27521675 [No Abstract] [Full Text] [Related]
12. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa. Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868 [TBL] [Abstract][Full Text] [Related]
13. Retinitis pigmentosa and other dystrophies. Sahel J; Bonnel S; Mrejen S; Paques M Dev Ophthalmol; 2010; 47():160-167. PubMed ID: 20703049 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis. Huang Q; Chen R; Lin X; Xiang Z PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491 [TBL] [Abstract][Full Text] [Related]
15. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Grover S; Apushkin MA; Fishman GA Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Querques G; Prascina F; Iaculli C; Noci ND Int Ophthalmol; 2009 Apr; 29(2):103-7. PubMed ID: 18157710 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study. Sudhalkar A; Kodjikian L; Borse N Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1369-1374. PubMed ID: 28378252 [TBL] [Abstract][Full Text] [Related]
18. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors. Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600 [TBL] [Abstract][Full Text] [Related]
19. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Fishman GA; Apushkin MA Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269 [TBL] [Abstract][Full Text] [Related]
20. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]